China OKs first homegrown vaccine

It has already been approved in the United Arab Emirates and Bahrain, and is slated for use next in Morocco.Other countries have also been buying doses of another Chinese vaccine candidate, made by Sinovac Biotech. The Sinopharm vaccine had already been given to groups such as health care professionals and essential workers under emergency-use guidelines as part of China’s program to inoculate 50 million people before the Lunar New Year holiday in February. AstraZeneca is expected to cost about $2.50 a dose, while Russia has said its doses will be priced at $10 for the global market. It would also open the path for the shots to be distributed in the global vaccine consortium, COVAX, and potentially in countries that don’t have their own regulatory agencies.China is eager to ship its vaccines globally, driven by a desire to repair the damage to its image caused by the pandemic that started a year ago in the central city of Wuhan.Technically, China granted conditional approval for the vaccine, meaning that research is still ongoing, and the company will be required to submit follow-up data as well as reports of any adverse effects after the vaccine is sold on the market, Chen Shifei, the deputy commissioner of the National Medical Products Administration, told a news conference. Some countries roll out experimental COVID-19… That means the cost will also be important. 05:51

In addition to the emergency vaccinations already underway in China, the country plans to start vaccinating high-risk population, such as seniors as well as people with existing chronic illnesses. One official said it would be affordable for the Chinese public, but another jumped in to clarify that it will be free. Securing WHO’s so-called pre-qualification could go some way toward assuring the rest of the world about the quality of Chinese vaccines, which already face a reputation problem back home. While the Pfizer and Moderna shots have been greeted with much fanfare in the West, those shots must be stored at ultra-cold or freezer temperatures, complicating distribution.The Sinopharm vaccine, like the AstraZeneca one, could be easier for countries around the world to handle since they can be stored at normal fridge temperatures.Both shots, as well as Russia’s Sputnik, are expected to be supply much of the developing world. “But at the same time we have to temper the excitement. But the go-ahead should allow it to be supplied more broadly at home and moves Beijing closer to being able to ship it abroad. The greenlight came a day after the state-owned company announced that preliminary data from last-stage trials had shown it to be 79.3% effective. It comes one day after British regulators authorized AstraZeneca’s inexpensive and easy-to-handle vaccine.Both shots have been closely watched by developing countries, many of which have been unable to secure the Pfizer and Moderna doses being snapped up by rich nations. President Xi Jinping had previously vowed to donate a Chinese-made vaccine as a public good to the world.The Sinopharm shot is already under mass production, though officials did not answer questions about current capacity. Sinopharm, which has another shot under development, is one of at least five Chinese developers that are in a global race to create vaccines for the disease that has killed more than 1.8 million people. John, an immunologist at the Duke-NUS Medical School in Singapore. That announcement did not detail the size of the control group, how many people were vaccinated and at what point the efficacy rate was reached after injection, and experts have cautioned that trial data needs to be shared.Officials have said the vaccine standards were developed in “close cooperation” with the World Health Organization. China OKs first homegrown vaccine as COVID-19 surges globally

By Associated Press

December 31, 2020 / 11:59 AM
/ AP

Rich nations dominate vaccine market

Rich nations dominate vaccine market

04:41

Beijing — China authorized its first homegrown COVID-19 vaccine for general use Thursday, adding another shot that could see wide use in poorer countries as the virus surges back around the globe. Final proof of its effectiveness will depend on publication of more data. “This is very exciting that there is another vaccine and one that can be distributed in locations that don’t have the cold chain,” said Ashley St. Pfizer’s vaccine costs about $20, while Moderna’s is $15 to $25, based on agreements with the U.S. Turkey received shipments this week of 3 million doses, and Indonesia and Brazil have also purchased it.Belarus and Argentina both launched mass vaccinations Wednesday using Russia’s vaccine, and Guinea has begun giving it to government officials. China, Russia using vaccines to expand reach

05:58

Chinese officials declined to name a particular price and gave conflicting statements about it. We have to understand the long term efficacy, effect on transmission and effect on severe disease.”
First published on December 31, 2020 / 11:59 AM government. Pakistan’s science minister said Thursday that his government will buy 1.2 million doses of a Sinopharm shot, two days after its death toll topped 10,000. Officials did not say what percentage of the population they will vaccinate in China.